지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2019.1
- 수록면
- 19 - 29 (11page)
이용수
초록· 키워드
오류제보하기
Conventional chemoembolization using Lipiodol-based regimens was introduced in the 1980s, and it is currently recommended as the primary treatment modality for patients with unresectable, intermediate, or locally advanced hepatocellular carcinoma (HCC) by the international guidelines. For better therapeutic efficacy and safety, chemoembolization should be performed as selectively as possible through tumor-feeding arteries, based on the detection of arterial supply to the HCC. With the technical advancement of flat-panel detector, cone-beam computed tomography (CBCT) is mounted on the C-arm of the angiographic machine. CBCT facilitates the detection of small occult HCCs and fine tumor-feeding arteries, recognition of extrahepatic collateral supply, navigation of a microcatheter to the target feeding arteries, prevention of non-target embolization, and intraprocedural assessment of the completeness of treatment with chemoembolization. These functions performed by CBCT ultimately improve the safety and efficacy of chemoembolization and may contribute to improving the prognosis of the patient with HCC.
목차
등록된 정보가 없습니다.
참고문헌 (46)
참고문헌 신청
Llovet JM / 2002 / Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:a randomised controlled trial / Lancet 359:1734~1739
Lo CM / 2002 / Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma / Hepatology 35:1164~1171
Korean Liver Cancer Study Group / 2015 / 2014 Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guideline for the Management of Hepatocellular Carcinoma / Korean Journal of Radiology 16(3):465~522
European Association for the Study of the Liver / 2018 / EASL clinical practice guidelines:management of hepatocellular carcinoma / J Hepatol 69:182~236
Heimbach JK / 2018 / AASLD guidelines for the treatment of hepatocellular carcinoma / Hepatology 67:358~380
Lo CM / 2002 / Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma / Hepatology 35:1164~1171
Korean Liver Cancer Study Group / 2015 / 2014 Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guideline for the Management of Hepatocellular Carcinoma / Korean Journal of Radiology 16(3):465~522
European Association for the Study of the Liver / 2018 / EASL clinical practice guidelines:management of hepatocellular carcinoma / J Hepatol 69:182~236
Heimbach JK / 2018 / AASLD guidelines for the treatment of hepatocellular carcinoma / Hepatology 67:358~380
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Comparison of two transarterial chemoembolization strategies for hepatocellular carcinoma
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
-
Health-Related Quality of Life of Patients with Intermediate Hepatocellular Carcinoma after Liver Resection or Transcatheter Arterial Chemoembolization
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Rupture of hepatocellular carcinoma after transcatheter arterial chemoembolization: A case report
International Journal of Gastrointestinal Intervention
2021 .01
-
Long-term Survival of a Patient with a Large Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombosis and Spontaneous Tumor Rupture
Journal of Liver Cancer
2020 .01
-
Is Transarterial Chemoembolization Only Treatment Option in Patients with Intermediate Stage of Hepatocellular Carcinoma?: in Perspectives of Surgery
Journal of Liver Cancer
2020 .01
-
Advances in Management of Hepatocellular Carcinoma
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective
Clinical and Molecular Hepatology
2023 .04
-
Chemoembolization versus Radiotherapy for Single Hepatocellular Carcinomas of ≤3 cm Unsuitable for Image-Guided Tumor Ablation
Gut and Liver
2024 .01
-
A Case of Cryptogenic Organizing Pneumonia after Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma
Tuberculosis and Respiratory Diseases
2015 .01
-
Multidisciplinary treatment with immune checkpoint inhibitors for advanced stage hepatocellular carcinoma
Journal of Liver Cancer
2022 .03
-
Therapy-related myeloid neoplasms after transcatheter arterial chemoembolization for hepatocellular carcinoma
Blood Research
2021 .12
-
Use of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective study
Journal of Liver Cancer
2023 .03
-
Combined Transarterial Chemoembolization and External Beam Radiotherapy in a Patient with Recurrent Huge Hepatocellular Carcinoma after Hepatic Resection
Journal of Liver Cancer
2020 .01
-
Management of Hepatocellular Carcinoma: Current Status and Future Directions
Gut and Liver
2015 .01
-
폐전이를 보인 단일결절형 거대 간세포암종 환자에서 순차적인 경동맥화학색전술과 Sorafenib으로 완전관해를 보인 1예
Journal of Liver Cancer
2016 .01
-
Efficacy of Hepatic Arterial Infusion Chemotherapy and Radiofrequency Ablation against Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization and Vascular Variation: A Case Study
고신대학교 의과대학 학술지
2021 .12
-
Current Trends and Recent Advances in Diagnosis, Therapy, and Prevention of Hepatocellular Carcinoma
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea
Clinical and Molecular Hepatology
2020 .01
-
Role of Surgery in Stage IV Hepatocellular Carcinoma (HCC)
대한임상종양학회 학술대회지
2015 .02
-
The prime time for management of hepatocellular carcinoma in Hong Kong
Clinical and Molecular Hepatology
2023 .04
이 논문의 저자 정보
최근 본 자료
댓글(0)
0